CAMBRIDGE, Mass., Nov. 2 /PRNewswire/ -- Xanthus Pharmaceuticals, Inc.,
a privately-held oncology drug development company, today announced that it
will be presenting at the following upcoming investment conferences in
November:
* Richard T. Dean, Ph.D., Chief Executive Officer, will present at the
Rodman & Renshaw 8th Annual Healthcare Conference on November 7, 2006
at 4:35pm at the Palace Hotel in New York.
* Richard T. Dean, Ph.D., Chief Executive Officer, will present at the
CIBC World Markets 17th Annual Healthcare Conference on November 8,
2006 at 1:50pm at the Waldorf-Astoria in New York.
* Robert L. Capizzi, MD, Senior Vice President, Chief Medical Officer will
present at the ThinkEquity Partners ThinkTank Conference on November 10,
2006 at 2:00pm at the Ritz Carlton in New York.
A live audio webcast of the CIBC presentation will be available on the
Company's website located at http://www.xanthus.com. A replay of the
presentations will be posted on the Xanthus website approximately thirty
minutes after the event.
About Xanthus Pharmaceuticals, Inc.
Xanthus Pharmaceuticals, Inc. is developing a portfolio of novel,
clinical-stage, small-molecule oncology candidates through a management
team whose accomplished track record encompasses all aspects of drug
development, from discovery through regulatory approval and
commercialization. The Company is applying its expertise both to advance
its current pipeline and expand it into indications of unmet medical need
beyond oncology.
Xanthus is headquartered in Cambridge, Massachusetts with an additional
facility in Montreal, Quebec. More information is available at
http://www.xanthus.com.
Contacts:
Kari Watson, MacDougall Biomedical Communications, Inc. -
kwatson@macbiocom.com or (508) 647-0209
Lisa Terry, Xanthus Pharmaceuticals, Inc. - lisa.terry@xanthus.com or
(617) 225-0522, x 105
SOURCE Xanthus Pharmaceuticals, Inc.
 back to top
Related links:
http://www.xanthus.com
CONTACT:
Lisa Terry of Xanthus Pharmaceuticals, Inc.,
+1-617-225-0522, ext. 105, lisa.terry@xanthus.com; or Kari Watson
of MacDougall Biomedical Communications, Inc., +1-508-647-0209,
kwatson@macbiocom.com
|
